Genetic Test Evaluation

understanding how genetic tests impact patient management

Genetic Testing for Alpha-1 Antitrypsin Deficiency Associated with Chronic Liver Disease

July 31, 2018

This report evaluates the clinical utility of SERPINA1 genetic testing to diagnose alpha-1 antitrypsin deficiency (AATD) in patients, including children, with unexplained chronic liver disease, and in first-degree relatives of individuals with known AATD.